Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Change in Cash (2016 - 2025)

Nephros (NEPH) has 16 years of Change in Cash data on record, last reported at $97000.0 in Q3 2025.

  • For Q3 2025, Change in Cash rose 115.57% year-over-year to $97000.0; the TTM value through Sep 2025 reached $2.7 million, up 225.36%, while the annual FY2024 figure was -$547000.0, 181.28% down from the prior year.
  • Change in Cash reached $97000.0 in Q3 2025 per NEPH's latest filing, down from $993000.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $1.3 million in Q4 2024 and bottomed at -$1.6 million in Q1 2022.
  • Average Change in Cash over 5 years is -$162000.0, with a median of -$239000.0 recorded in 2022.
  • Peak YoY movement for Change in Cash: crashed 1704.65% in 2022, then surged 513.65% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$377000.0 in 2021, then increased by 18.83% to -$306000.0 in 2022, then dropped by 2.94% to -$315000.0 in 2023, then soared by 513.65% to $1.3 million in 2024, then plummeted by 92.56% to $97000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were $97000.0 in Q3 2025, $993000.0 in Q2 2025, and $321000.0 in Q1 2025.